Arca
Skip to content
Tools
Tools

Nematode GABA-A receptor

Complex group in Onchocercidae that 2 drugs act on.

  • Drugs that act on it: 2
  • Approved: 2
  • In phases 1 to 3: 0
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 2

Approved2

  • Diethylcarbamazine
  • Piperazine citrate anhydrous

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DiethylcarbamazineApprovedPfizerSmall moleculePositive modulatorNematode GABA-A receptor positive modulator3
        Piperazine citrate anhydrousApproved—Small moleculePositive modulatorNematode GABA-A receptor positive modulator0

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 3 in all, from ClinicalTrials.gov.
        Better Options for Lymphatic Filariasis TreatmentDiethylcarbamazinePhase 3RecruitingMedicines Development for Global HealthSep 8, 2025
        Safety and Efficacy of Novel Combination Regimens for Treatment of OnchocerciasisDiethylcarbamazinePhase 2Active, not recruitingWashington University School of MedicineOct 6, 2023
        Host Response to Infection and Treatment in Filarial DiseasesDiethylcarbamazine—Active, not recruitingNational Institute of Allergy and Infectious Diseases (NIAID)Nov 4, 1999

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2364676, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.